Home > Insider Trading > Filing (0001437749-10-001101)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1375623	Immunosyn Corp	IMYN	Biological Products, (No Disgnostic Substances) (2836)	205322896

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1385168	T James Miceli	10815 Rancho Bernardo Dr #101 San Diego CA 92127		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2007-11-13	500,000	$0.00	500,000	No	4	J	Direct
Common Stock	Acquisiton	2007-11-13	12,710,000	$0.00	85,634,180	No	4	J	Indirect	by wife
Common Stock	Acquisiton	2009-07-07	10,000	$0.07	510,000	No	4	P	Direct
Common Stock	Acquisiton	2009-07-08	21,500	$0.08	531,500	No	4	P	Direct
Common Stock	Acquisiton	2009-07-08	15,000	$0.09	546,500	No	4	P	Direct
Common Stock	Acquisiton	2009-07-13	10,000	$0.08	556,500	No	4	P	Direct
Common Stock	Acquisiton	2009-07-14	10,000	$0.10	566,500	No	4	P	Direct
Common Stock	Acquisiton	2009-07-14	10,000	$0.09	576,500	No	4	P	Direct
Common Stock	Acquisiton	2009-07-15	51,500	$0.09	628,000	No	4	P	Direct
Common Stock	Acquisiton	2009-07-15	10,000	$0.10	638,000	No	4	P	Direct
Common Stock	Acquisiton	2009-06-30	50,000	$0.07	688,000	No	4	P	Direct
Common Stock	Acquisiton	2009-07-06	2,857	$0.06	690,857	No	4	P	Direct
Common Stock	Acquisiton	2009-07-10	10,000	$0.09	700,857	No	4	P	Direct
Common Stock	Acquisiton	2009-07-14	30,000	$0.09	730,857	No	4	P	Direct
Common Stock	Acquisiton	2009-07-20	12,780	$0.08	743,637	No	4	P	Direct
Common Stock	Acquisiton	2009-07-22	50,000	$0.08	793,637	No	4	P	Direct
Common Stock	Acquisiton	2009-07-22	2,500	$0.07	796,137	No	4	P	Direct
Common Stock	Acquisiton	2009-07-27	50,000	$0.07	846,137	No	4	P	Direct
Common Stock	Acquisiton	2009-07-28	50,000	$0.07	896,137	No	4	P	Direct
Common Stock	Acquisiton	2009-08-26	77,000	$0.06	973,137	No	4	P	Direct
Common Stock	Acquisiton	2009-08-31	100,000	$0.05	1,073,137	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Indirect	by wife
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	85,634,180	Indirect	by entities
Common Stock	12,710,000	Indirect	by wife

Footnotes

Represents change in form of ownership by transfer and distribution from Cuxhaven Holdings Ltd., which was wholly owned by the reporting person.
Represents change in form of ownership by wife of reporting person by transfer and distribution from Cuxhaven Holdings Ltd., which was wholly owned by the reporting person. The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or any other purposes.
Purchased in the reporting person's 401(k) plan account.
Purchased in the reporting person's IRA account.
Indirect interests owned by Argyll Biotechnologies LLC, Argyll Equities LLC and Padmore Holdings, Ltd. in which the reporting person owns ownership interests. Indirect ownership reported reflects reporting person's proportionate interest.